Immediate Impact
2 from Science/Nature 90 standout
Citing Papers
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Works of Christopher Colameco being referenced
CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Christopher Colameco | 282 | 283 | 67 | 79 | 9 | 332 | |
| Fouad Alchami | 176 | 177 | 75 | 37 | 8 | 314 | |
| Farida Souami | 155 | 170 | 68 | 32 | 7 | 256 | |
| Bharani Dharan | 118 | 141 | 58 | 38 | 10 | 316 | |
| Tong Luo | 199 | 220 | 61 | 63 | 10 | 304 | |
| Dianne Spillman | 125 | 170 | 60 | 25 | 8 | 365 | |
| Elaine Wiegert | 128 | 74 | 58 | 38 | 9 | 306 | |
| Jacob P. Wagner | 190 | 135 | 64 | 32 | 9 | 315 | |
| J. P. Bizzari | 116 | 228 | 34 | 60 | 10 | 339 | |
| Pavel Bezecny | 194 | 170 | 99 | 80 | 8 | 358 | |
| Margherita Carucci | 189 | 159 | 90 | 46 | 7 | 286 |
All Works
Loading papers...